Apellis Pharmaceuticals, Inc (NASDAQ:APLS) Receives Average Rating of Moderate Buy from Brokerages etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.
Inspire Advisors LLC reduced its stake in shares of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) by 50.9% during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 6,115 shares of the company’s stock after selling 6,342 shares during the period. Inspire […]
Orion Portfolio Solutions LLC lifted its holdings in Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) by 64.2% in the 3rd quarter, Holdings Channel.com reports. The fund owned 27,396 shares of the company’s stock after buying an additional 10,713 shares during the quarter. Orion Portfolio Solutions LLC’s holdings in Apellis Pharmaceuticals were worth $1,042,000 at the […]
Apellis Announces Preliminary Fourth Quarter and Full Year 2023 U S Net Product Revenues tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Apellis Announces Preliminary Fourth Quarter and Full Year 2023 U S Net Product Revenues marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.